Carrier screening for cystic fibrosis in a prenatal setting

Genetic Testing

Volumn 5, Issue 2, 2001, Pages 117-125

  Delvaux, I ^a   van Tongerloo, A ^a   Messiaen, L ^a   De Bie, S ^a   Mortier, G ^a   De Paepe, A ^a   Van Loon, C ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b INNOGENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISTRESS SYNDROME; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; HETEROZYGOTE; HUMAN; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; PILOT STUDY; PRENATAL SCREENING; RISK ASSESSMENT;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CYSTIC FIBROSIS; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PILOT PROJECTS; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 0034871790     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065701753145574     Document Type: Article

References (9)

1. Psychological impact of population-based carrier testing for cystic fibrosis: 3-Year follow-up
2. The impact of population based screening for carriers of cystic fibrosis
3. Cystic fibrosis
4. Uptake and impact of carrier testing for cystic fibrosis
5. Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference
6. Cystic fibrosis carrier population screening in the primary care setting
7. Analysis of 22 cystic fibrosis mutations in 62 patients from the Flanders, Belgium, reveals a high prevalence of Nordic Mutation 394 del TT